Cronos Group (TSE:CRON) Sets New 12-Month High – Time to Buy?

Cronos Group Inc. (TSE:CRON)’s stock price reached a new 52-week high on Monday . The stock traded as high as C$4.72 and last traded at C$4.71, with a volume of 79273 shares traded. The stock had previously closed at C$4.58.

Wall Street Analyst Weigh In

Separately, TD raised their price target on shares of Cronos Group from C$5.50 to C$6.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Cronos Group has a consensus rating of “Buy” and a consensus price target of C$4.92.

Cronos Group Stock Up 3.1%

The company has a debt-to-equity ratio of 0.12, a quick ratio of 24.01 and a current ratio of 16.18. The company has a fifty day simple moving average of C$4.02 and a two-hundred day simple moving average of C$3.77. The firm has a market capitalization of C$1.74 billion, a PE ratio of 24.84, a PEG ratio of 0.12 and a beta of 1.13.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.